<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Autism</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Autism</journal-id>
<journal-title-group>
<journal-title>Molecular Autism</journal-title>
</journal-title-group>
<issn pub-type="epub">2040-2392</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26793298</article-id>
<article-id pub-id-type="pmc">4719563</article-id>
<article-id pub-id-type="publisher-id">68</article-id>
<article-id pub-id-type="doi">10.1186/s13229-016-0068-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Young</surname>
<given-names>Adam M. H.</given-names>
</name>
<address>
<email>ay276@cam.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chakrabarti</surname>
<given-names>Bhismadev</given-names>
</name>
<address>
<email>b.chakrabarti@reading.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roberts</surname>
<given-names>David</given-names>
</name>
<address>
<email>davemaryroberts@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lai</surname>
<given-names>Meng-Chuan</given-names>
</name>
<address>
<email>mcl45@cam.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff4"></xref>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suckling</surname>
<given-names>John</given-names>
</name>
<address>
<email>js369@cam.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff6"></xref>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baron-Cohen</surname>
<given-names>Simon</given-names>
</name>
<address>
<email>sb205@cam.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff8"></xref>
</contrib>
<aff id="Aff1"><label></label>Autism Research Centre, Department of Psychiatry, University of Cambridge, Douglas House, 18B Trumpington Road, Cambridge, UK </aff>
<aff id="Aff2"><label></label>School of Clinical Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, UK </aff>
<aff id="Aff3"><label></label>Centre for Integrative Neuroscience and Neurodynamics, School of Psychology and Clinical Language Science, University of Reading, Reading, UK </aff>
<aff id="Aff4"><label></label>Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Canada </aff>
<aff id="Aff5"><label></label>Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan </aff>
<aff id="Aff6"><label></label>Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Cambridge, UK </aff>
<aff id="Aff7"><label></label>Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK </aff>
<aff id="Aff8"><label></label>CLASS Clinic, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>20</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>9</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>9</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>4</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© Young et al. 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>Growing evidence points toward a critical role for early (prenatal) atypical neurodevelopmental processes in the aetiology of autism spectrum condition (ASC). One such process that could impact early neural development is inflammation. We review the evidence for atypical expression of molecular markers in the amniotic fluid, serum, cerebrospinal fluid (CSF), and the brain parenchyma that suggest a role for inflammation in the emergence of ASC. This is complemented with a number of neuroimaging and neuropathological studies describing microglial activation. Implications for treatment are discussed.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>NF-κB</kwd>
<kwd>Autism</kwd>
<kwd>Brain</kwd>
<kwd>Inflammation</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>The presence of inflammation in autism spectrum condition (ASC) is a concept that is gathering momentum. Traditionally, different forms of ASC have been recognised: Classic (or Kanner type) autism (which can entail general intellectual disability and language delay), Asperger syndrome (which entails no developmental language delay or intellectual disability) and syndromic forms of autism such as co-occurring with Rett syndrome, Fragile X syndrome, tuberous sclerosis complex and Timothy’s syndrome, to name a few [<xref ref-type="bibr" rid="CR29">29</xref>]. In DSM-5, these are now subsumed under a single umbrella term of autism spectrum disorder (ASD). In this article, we use the term autism spectrum condition (ASC) because the term ‘disorder’ is regarded by some as stigmatising and the term ‘condition’ acknowledges both the disability and the differences and strengths in such individuals.</p>
<p>The key behavioural features defining ASC are the presence of difficulties in social reciprocity and communication, alongside unusually narrow interests, repetitive behaviours and speech, insistence on sameness, and idiosyncratic sensory responses DSM-V® [<xref ref-type="bibr" rid="CR30">30</xref>]. Cognitively, ASC is described as a condition characterised by weakened central coherence [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], executive dysfunction [<xref ref-type="bibr" rid="CR76">76</xref>], and mentalising difficulties [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] alongside strengths in ‘systemizing’ [<xref ref-type="bibr" rid="CR5">5</xref>] and attention to detail [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. Genetic, environmental, neurological, and immunological factors contribute to its aetiology [<xref ref-type="bibr" rid="CR72">72</xref>].</p>
<p>Some, but not all, studies suggest that ASC involves early brain overgrowth [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. This is unlikely to be a universal phenomenon [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR73">73</xref>] and is one of the key factors that could be linked to the heterogeneity of the condition together with neuroinflammation. Nevertheless, there are a multitude of developmental reasons which could be responsible for this observation, including atypical pruning of synapses [<xref ref-type="bibr" rid="CR41">41</xref>] and, more recently, neuron density has been shown to play a significant role [<xref ref-type="bibr" rid="CR22">22</xref>], but this could also reflect neuroinflammation. Animal models have identified microglial priming as a major factor in a causal chain that leads to the wide spectrum of neuronal dysfunctions and behavioural phenotypes [<xref ref-type="bibr" rid="CR59">59</xref>]. Increased head size in people with ASC correlates positively with a history of allergic/immune disorders [<xref ref-type="bibr" rid="CR86">86</xref>]. In particular, there is an association between ASC and neuroinflammation in anterior regions of the neocortex [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR110">110</xref>], resulting from activation of microglia and astrocytes [<xref ref-type="bibr" rid="CR2">2</xref>]. Gene networks involved in immune processes are overexpressed in the brain of individuals with ASC [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>]. This has been linked to atypical expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in a number of cell types in ASC including neurons, astrocytes, and microglia [<xref ref-type="bibr" rid="CR107">107</xref>]. This has a linear relationship with pH changes localised to the lysosomal compartments of mature microglia [<xref ref-type="bibr" rid="CR107">107</xref>], indicating increased immune activity. Microglia play a critical role in the pruning of synapses, thus providing a potential bridge between the atypical synaptic pruning and the immune dysregulatory hypotheses of ASC [<xref ref-type="bibr" rid="CR78">78</xref>]. Below we review the mechanisms that may underlie neuroinflammation and the evidence at genetic and protein levels for each of these mechanisms (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of contributing immunological factors in ASC</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Level of biological processes</th><th>Immunological factors involved</th></tr></thead><tbody><tr><td>Genetic</td><td>IFN-γ, Toll-like receptors, T-cell receptor</td></tr><tr><td>Extracellular mediators</td><td>Maternal antibodies, cytokines and chemokines</td></tr><tr><td>Cell surface proteins</td><td>Human leukocyte antigen, Toll-like receptors</td></tr><tr><td>Intracellular signalling</td><td>mTOR, PTEN, NF-κB</td></tr><tr><td>Neural changes</td><td>Neuron density, glial proliferation</td></tr></tbody></table></table-wrap></p>
<sec id="Sec2">
<title>Genetic studies</title>
<p>Many loci have been implicated in the condition [<xref ref-type="bibr" rid="CR42">42</xref>]. Most recently, a number of recent breakthroughs have dramatically advanced our understanding of ASC from the standpoint of human genetics and neuropathology. These studies highlight the period of foetal development and the processes of chromatin structure, synaptic function, and neuron-glial signalling [<xref ref-type="bibr" rid="CR18">18</xref>]. A key component of genetic architecture is the allelic spectrum influencing trait variability. Recent studies have demonstrated that the total heritability of risk-associated genes is in the range of 50–60 % with common variants explaining the bulk of it [<xref ref-type="bibr" rid="CR40">40</xref>]. In a comparison of genome-wide linkage studies between autoimmune and inflammatory disorders in ASC, overlap of polymorphic markers were statistically significant [<xref ref-type="bibr" rid="CR8">8</xref>]. For a comprehensive list of the genes identified, see <ext-link ext-link-type="uri" xlink:href="http://www.grc.nia.nih.gov/branches/rrb/dna/atsmap.htm">http://www.grc.nia.nih.gov/branches/rrb/dna/atsmap.htm</ext-link>.</p>
<p>Where it is conceded that the chromosomal regions identified in these linkage studies and the specific variants of genes identified in genetic association studies are quite often not unique to any one disorder [<xref ref-type="bibr" rid="CR8">8</xref>]. Specific immunological genetic assays have been tested in panelled assays to test both sensitivity and specificity in diagnosing autism. Using a signature of differentially co-expressed genes that were enriched in translation and immune/inflammation function, the authors were able to identify boys with autism with 83 % accuracy [<xref ref-type="bibr" rid="CR85">85</xref>].</p>
</sec>
<sec id="Sec3">
<title>Extracellular mediators</title>
<sec id="Sec4">
<title>Maternal-foetal transfer</title>
<p>The involvement of an inflammatory pathogenesis in ASC likely originates during the gestational period [<xref ref-type="bibr" rid="CR59">59</xref>]. Autoantibodies are transferred from the mother to the child during pregnancy and are associated with a number of factors that affect both pregnancy and neonatal outcome [<xref ref-type="bibr" rid="CR100">100</xref>]. In a cohort of mothers of children with ASC, autoantibodies have been detected against critical neuronal components of foetal brain tissue samples [<xref ref-type="bibr" rid="CR109">109</xref>] as well as transfer of maternal neuro-specific proteins [<xref ref-type="bibr" rid="CR23">23</xref>]. These studies identified a range of unknown protein targets ranging from 30 to 250 kilodaltons (kDa) in size. Consecutive independent studies have identified autoantibodies that bind to novel proteins of 37, 39, and 73 kDa in size [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR104">104</xref>].</p>
<p>A number of models have been hypothesised to explain the transfer of anti-foetal brain autoantibodies [<xref ref-type="bibr" rid="CR58">58</xref>]. In one study, immunoglobulin G (IgG) isolated from mothers with children with ASC was transferred into rhesus macaque monkeys during mid-gestation and resulted in distinct behavioural changes in the offspring. In particular, the monkeys spent significantly less time in contact with their peers and spent more time in a non-social state. This was attributed to the specific IgG from mothers of children with ASC infusion and not observed in monkeys receiving IgG from control donors or monkeys that were saline treated [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. These observations have been replicated in mice [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. Whether the transfer of these auto-antibodies during gestation plays a role in the pathogenesis in ASC remains uncertain; however, it is clear that there is a potential association. Brimberg et al. [<xref ref-type="bibr" rid="CR13">13</xref>] describes mothers of an ASC child being found to be four times more likely to harbour anti-brain antibodies than other women of child-bearing age. Fundamentally, these processes may have a significant impact on neurodevelopment. Supporting this view is a recent study from Braunschweig et al. [<xref ref-type="bibr" rid="CR11">11</xref>] who have identified that lactate dehydrogenases A and B (LDH), cypin, stress-induced phosphoprotein 1 (STIP1), collapsin response mediator proteins 1 and 2 (CRMP1, CRMP2), and Y-box-binding protein comprise the seven primary antigens of maternal autoantibody-related (MAR) autism. This built on previous work which introduced the concept of studying the maternal plasma antibodies against both the maternal and fatal brain [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR87">87</xref>].</p>
<p>A number of animal studies have demonstrated that placenta to foetus transport can alter development. Specifically, Lin et al. [<xref ref-type="bibr" rid="CR63">63</xref>] used <italic>P. gingivalis</italic> in mice to demonstrate that maternal immune system stimulation can lead to elevated levels of pro-inflammatory cytokines in both the placenta and amniotic fluid, whilst at the same time decreasing the major anti-inflammatory cytokines TGF-β, IL-4, and IL-10. Maternal inoculation with Poly(I:C), as well as lipopolysaccharide (LPS), also in mice, have resulted in the animal displaying behavioural characteristics in keeping with ASC, including pre-pulse inhibition deficits, working memory deficits, and social interaction deficits [<xref ref-type="bibr" rid="CR80">80</xref>]. Blocking the action of these pro-inflammatory cytokines during maternal infection was observed to inhibit the development of such behaviour [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. Maternal LPS administration upregulates both tumour necrosis factor-alpha (TNF-α) and IL-1β mRNA expression in the foetuses of pregnant rats in a dose-dependent manner [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
</sec>
<sec id="Sec5">
<title>Cytokines and chemokines</title>
<p>Cytokines and chemokines are pleiotrophic proteins that coordinate the host response to infection as well as mediate normal, ongoing communication between cells of non-immune tissues, including the nervous system [<xref ref-type="bibr" rid="CR27">27</xref>]. As a consequence of this dual role, cytokines induced in response to an adverse stimuli (i.e. maternal infection or prenatal hypoxia) can profoundly impact fetal neurodevelopment. Aberrant levels of proinflammatory cytokines, interleukin 6 (IL-6), TNF-α and monocyte chemotactic protein-1 (MCP-1), not only in brain specimens and cerebrospinal fluid (CSF; [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]) but also in amniotic fluid [<xref ref-type="bibr" rid="CR1">1</xref>], index an active inflammatory process both in children and adults with ASC. These molecules act to increase immune cell recruitment and proliferation. Immune pathways are activated by proinflammatory cytokines such as TNF-α and IL-6 that stimulate the nuclear translocation of various transcription factors, including NF-κB that subsequently results in the potentiation of the immune response [<xref ref-type="bibr" rid="CR81">81</xref>]. This is tightly controlled in acute infection and lasts for a limited time. However, the presence of such molecules in the absence of an acute stimulus is an atypical response. An atypical inflammatory response has been observed in peripheral samples to show similar changes [<xref ref-type="bibr" rid="CR56">56</xref>] as well as decreases in anti-inflammatory protein IL-10 [<xref ref-type="bibr" rid="CR56">56</xref>]. In a larger multi-analyte profiling (MAP) analysis, Suzuki et al. [<xref ref-type="bibr" rid="CR98">98</xref>] reported from a total of 48 analytes examined, the plasma concentrations of IL-1β, IL-1RA, IL-5, IL-8, IL-12(p70), IL-13, IL-17, and growth regulated oncogene-alpha (GRO-α) were significantly higher in individuals with ASC compared with the corresponding values of matched controls, after correction for multiple comparisons. Upregulation of inflammation-related molecules has also been found to be characteristic for adult males (but not females) with Asperger syndrome [<xref ref-type="bibr" rid="CR95">95</xref>]. In mid-gestation maternal serum, elevated concentrations of IFN-γ, IL-4, and IL-5 were significantly associated with a 50 % increased risk of ASC, regardless of ASC onset type and the presence of intellectual disability [<xref ref-type="bibr" rid="CR45">45</xref>].</p>
<p>The main issue surrounding the reporting of serum results is that they show considerable within- and between-group variability. As such, the subtle differences found may indicate the presence of separate subgroups of the condition [<xref ref-type="bibr" rid="CR60">60</xref>]. For example, statistical clustering analysis on large-scale clinical data suggests the presence of subgroups with ASC characterised by co-occurrence of infectious disorder [<xref ref-type="bibr" rid="CR31">31</xref>], which could be related to physiological atypicality related to inflammatory processes. Further analysis using appropriately powered studies will be required in order to gauge the potential explanatory power of this hypothesis.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Cell surface proteins</title>
<p>In contrast to cytokines and chemokines, major histocompatibility complex (MHC) family members have very short intracellular domains not thought to function in intracellular signalling cascades, but instead by interacting with a variety of receptors during cell-mediated immunity [<xref ref-type="bibr" rid="CR92">92</xref>]. Together with TLRs, they form a key role in activity-dependent brain development and plasticity as well as regulating the immune response [<xref ref-type="bibr" rid="CR84">84</xref>]. Specifically, it has been observed that (MHC) class I molecule H2-D(b) is essential for synapse elimination in the retinogeniculate system [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR67">67</xref>].</p>
<p>Genetically, immune dysfunction in ASC has been suggested to included the MHC region, as this is an immunologic gene cluster whose gene products are class I, II, and III molecules. Class I and II molecules are associated with antigen presentation. The human leukocyte antigen (HLA) genes are among the strongest predictors of risk for autoimmune conditions. Some studies have observed that different HLA haplotypes are associated with neurodevelopmental conditions such as ASC [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR55">55</xref>] and schizophrenia [<xref ref-type="bibr" rid="CR94">94</xref>]. Stubbs et al. [<xref ref-type="bibr" rid="CR97">97</xref>] initially demonstrated that mothers of children with ASC share HLA haplotypes with their children more often than in non-affected pairs. Recent evidence has suggested that impairments of innate immunity, originating with cell surface proteins, may play an important role in ASC. Enstrom et al. [<xref ref-type="bibr" rid="CR33">33</xref>] demonstrated an improved responsiveness to signalling via select TLRs: TLR 2, TLR 4, and conversely a decreased production of cytokines following stimulation of TLR 9.</p>
</sec>
<sec id="Sec7">
<title>Intracellular signalling pathways</title>
<p>Another distinct pathway to be implicated in ASC is a well-known family of transcription factors, the nuclear factor kappa B (NF-κB), which is one of the key players in the regulation of inflammatory responses [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. This transcription factor is constitutively expressed in the cytoplasm and is inhibited by inhibitor κB (I κB), which binds NF-κB, masking its nuclear localization signal and retaining it in the cytoplasm [<xref ref-type="bibr" rid="CR44">44</xref>]. NF-κB activity is attributed to Rel/NF-κB family proteins forming homodimers and heterodimers through the combination of the subunits p65 (or RelA), p50, p52, c-Rel, or RelB [<xref ref-type="bibr" rid="CR81">81</xref>]. Cytokines, chemokines, and reactive oxygen species are among a number of key mediators that induce NF-κB by activating IκB kinases [<xref ref-type="bibr" rid="CR77">77</xref>]. These phosphorylate IκBα, leading to its polyu biquitination and degradation [<xref ref-type="bibr" rid="CR43">43</xref>], allow NF-κB to migrate to the nucleus, where it activates the transcription of various proinflammatory genes.</p>
<p>NF-κB has been found to be aberrantly expressed in the orbitofrontal cortex in postmortem studies of adults with ASC [<xref ref-type="bibr" rid="CR107">107</xref>]. Expression was most abundant in microglia followed by astrocytes compared to neurons. However, samples from other frontal lobe or cerebellar samples have not shown similar increases [<xref ref-type="bibr" rid="CR64">64</xref>] suggesting a localisation of aberrant expression. Peripherally, NF-κB was upregulated in TNF-α and LPS stimulated peripheral blood monocytes (PBMCs) [<xref ref-type="bibr" rid="CR71">71</xref>]. The upregulation of expression was found to be similar in that Young et al. [<xref ref-type="bibr" rid="CR107">107</xref>] reported a 2.9-fold increase in NF-κB expression centrally compared to a 2.2-fold increase reported peripherally [<xref ref-type="bibr" rid="CR71">71</xref>]. The significance of this similarity is difficult to ascertain as there is significant heterogeneity of brain parenchyma in response to inflammatory stimuli [<xref ref-type="bibr" rid="CR108">108</xref>]. The implication of the NF-κB signalling pathway in ASC further supports a potential role for neuroinflammation. Further work is needed to identify whether upregulation of NF-κB plays a role in initiating the signalling cascade or whether it is a result of aberrant stimulation.</p>
</sec>
<sec id="Sec8">
<title>Neuroanatomical changes</title>
<p>The ultrastructural morphology in ASC has been described as having atypical microglial and astroglial activation [<xref ref-type="bibr" rid="CR101">101</xref>]. Prominent histological changes have been described in the cerebellum, characterised by a patchy loss of neurons in the Purkinje cell layer (PCL) and granular cell layer (GCL) [<xref ref-type="bibr" rid="CR101">101</xref>] as well as a reduction in neuron number in the amygdalae and fusiform gyrus [<xref ref-type="bibr" rid="CR89">89</xref>]. Glial activation has been widely observed throughout a number of independent studies. Vargas et al. [<xref ref-type="bibr" rid="CR101">101</xref>] observed an increase in glial fibrillary acidic protein (GFAP) concentration in the white matter of the middle frontal gyrus (MFG) and anterior cingulate gyrus (ACG). An increased ratio of CD11c-positive, mature (highly active) microglia was observed in the orbitofrontal cortex and showed strong correlation with cell signalling molecules [<xref ref-type="bibr" rid="CR107">107</xref>]. Microglial activation and increased microglial density was also observed in the dorsolateral prefrontal cortex in ASC [<xref ref-type="bibr" rid="CR69">69</xref>]. Morphological alterations included somal enlargement, process retraction and thickening, and extension of filopodia from processes [<xref ref-type="bibr" rid="CR69">69</xref>]. They also described a significant increase in microglial somal volume in the white matter. Microglial cell density was increased in the grey matter with non-significant trends in somal volume [<xref ref-type="bibr" rid="CR69">69</xref>]. A recent study by Paolicelli and Gross [<xref ref-type="bibr" rid="CR78">78</xref>] suggests a central role for microglia in synaptic pruning, a process that has been suggested to be aberrant in the developing brain in ASC [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
<p>Magnetic resonance spectroscopy (MRS) has provided significant insight into the ultrastructural morphology in ASC. Myo-inositol (Ins) is a metabolic compound located mostly in astrocytes. High Ins levels are thought to indicate an increase in astrocyte populations and are particularly abundant in neuroinflammation [<xref ref-type="bibr" rid="CR10">10</xref>]. Interestingly, increased Ins levels have been demonstrated to impact on performance IQ scores in individuals with ASC [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
<p>The resonance group attributed to the glutamine-glutamate-GABA complex (Glx) includes contributions from both glutamate and its precursor glutamine. Very little glutamate penetrates the blood–brain barrier, so local synthesis is essential. De novo synthesis is mediated mainly by astrocytes, and as such, in vivo levels can be altered in neuroinflammation [<xref ref-type="bibr" rid="CR61">61</xref>]. Glutamate synthesised by astrocytes is converted to glutamine via the enzyme glutamine synthetase and exported to neurons via multiple transporters [<xref ref-type="bibr" rid="CR26">26</xref>]. In neurons, glutamine is reconverted into glutamate using the mitochondrial enzyme phosphate-activated glutaminase and then packaged into synaptic vesicles for release [<xref ref-type="bibr" rid="CR61">61</xref>]. Release of glutamate initiates signalling events in excitatory neurotransmission; transmission is terminated by the removal of glutamate from the extracellular space, predominantly via astrocytic glutamate transporters. This overall cycle of synthesis, release, and recovery of glutamate is referred to as the glutamate–glutamine cycle [<xref ref-type="bibr" rid="CR50">50</xref>].</p>
<p>DeVito et al. [<xref ref-type="bibr" rid="CR28">28</xref>] described widespread decrease in N-acetylaspartate (NAA) and Glx among people with ASC, with reductions observed in both the cerebral grey matter and the cerebellum. In a sample of adults with ASC, there was also a significant decrease in concentration of Glx, as well as choline, creatine (Cr) and NAA, in the basal ganglia [<xref ref-type="bibr" rid="CR51">51</xref>]. A reduction in Glx would classically be attributed to a reduction in neuron density. Nevertheless, inflammatory molecules can also contribute to inhibiting the astrocytic glutamate reuptake [<xref ref-type="bibr" rid="CR53">53</xref>] and by inducing changes in glutamate receptor subunit expression, thus leading to reduced intracellular levels of Glx [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
</sec>
<sec id="Sec9">
<title>Specificity of neuroinflammation</title>
<p>Neuroinflammation is emerging as a common finding in neurological and neuropsychiatric phenotypes. Most recently, it emerged as a finding in large genetic analyses of schizophrenia, bipolar disorder, and major depression [<xref ref-type="bibr" rid="CR75">75</xref>]. This prompts the question of the specificity of inflammation as a contributing mechanism in the emergence of ASC. Furthermore, it promotes ongoing discussion on whether this is a causal or reactive process. What is certain is that, regardless of whether inflammation is specific to a condition or general to a majority of psychiatric conditions, if it is present, it should be treated and whether it forms part of a multisystme pathology, it should be treated and the response evaluated to observe whether there is a significant cognitive change. Clarifying the roles of various neuroinflammatory processes, causal (aetiological) or reactive, in neurodevelopmental conditions, also serves as a useful angle to delineate ubiquitous pathogenetic processes across all kinds of atypical neurodevelopment from specific mechanisms or reactive processes that mark one clinical diagnosis but not others.</p>
</sec>
<sec id="Sec10">
<title>Evidence against inflammation as a contributing mechanism in autism</title>
<p>There have been a few studies that failed to identify atypical inflammatory activity in ASC [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. Voineagu et al. [<xref ref-type="bibr" rid="CR102">102</xref>] detail that the immune changes observed in their study of convergent molecular pathology have a less pronounced genetic component and thus are most likely either secondary phenomena or caused by environmental factors. Some have even gone as far to say that there is evidence that the immune response is not overactivated [<xref ref-type="bibr" rid="CR64">64</xref>]. Whilst these studies are important, they have not been replicated to the extent of papers supporting a role for inflammation in the pathogenesis of ASC. It is also important to consider that the scale of the inflammatory response is so vast that it is possible to target inflammatory mediators which may not contribute to the condition. This is well presented in a recent meta-analysis looking at the cytokine response in autism [<xref ref-type="bibr" rid="CR66">66</xref>]. Where 19 cytokines were assessed, only 7 were observed to have significantly different levels in ASC.</p>
</sec>
</sec>
<sec id="Sec11">
<title>Conclusions</title>
<p>An emerging focus of research into the aetiology of ASC has suggested neuroinflammation as one candidate underlying biological model. With over 1000 candidate genes associated with it, ASC has a strong genetic component [<xref ref-type="bibr" rid="CR70">70</xref>]. Similar to most medical conditions, however, there is also a significant environmental component in place, through gene-environmental interplay such as epigenetic mechanisms. The study of inflammation in ASC provides an excellent opportunity to dissect potential gene-environmental interplay. Here, we have highlighted some of the common indications of immunological dysregulation as potential contributing pathogenic processes for, at least certain subgroups of, individuals with ASC. Nevertheless, it is unclear whether the role of inflammation in ASC induces epigenetic change, via the activation of signalling cascades, or whether it is a direct result of genetic mutation and downstream effects. Whilst there is a growing body of work to support the role of inflammation in ASC, the greatest area of weakness in the field is that in general, the findings tend to be from individual studies and rarely are these replicated. Future work is needed to demonstrate what are essentially preliminary findings in large-scale studies. How much of a role, if any, neuroinflammation has on the emergence of ASC and contributing to its aetiological heterogeneity remains to be clarified.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ASC</term>
<def>
<p>autism spectrum condition</p>
</def>
</def-item>
<def-item>
<term>NF-κB</term>
<def>
<p>nuclear factor kappa-light-chain enhancer of activated B cells</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare that they have no competing interests.</p>
</fn>
<fn>
<p>
<bold>Authors’ contributions</bold>
</p>
<p>AMHY and DR performed the literature review, and AMHY wrote the manuscript. BC and MCL assisted with writing the manuscript and the provided continual supervision throughout the project. JS and SBC designed the study and provided overall supervision and final critical review of the manuscript. All authors read and approved the final manuscript.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>SBC was supported by the MRC and the Autism Research Trust and M-CL by the William Binks Autism Neuroscience Fellowship, during the period of this work.</p>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdallah</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bonefeld-Jørgensen</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Nørgaard-Pedersen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hougaard</surname>
<given-names>DM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study</article-title>
<source/>Cytokine
          <year>2013</year>
<volume>61</volume>
<issue>2</issue>
<fpage>370</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2012.11.015</pub-id>
<pub-id pub-id-type="pmid">23267761</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Ushakov</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Ferenczi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saffell</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Morphoregulation by acetylcholinesterase in fibroblasts and astrocytes</article-title>
<source/>J Cell Physiol
          <year>2008</year>
<volume>215</volume>
<issue>1</issue>
<fpage>82</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.21288</pub-id>
<pub-id pub-id-type="pmid">17948252</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Enstrom</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Krakowiak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes</article-title>
<source/>J Neuroimmunol
          <year>2008</year>
<volume>204</volume>
<issue>1-2</issue>
<fpage>149</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.07.006</pub-id>
<pub-id pub-id-type="pmid">18762342</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balosso</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ravizza</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pierucci</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Calcagno</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Invernizzi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Di Giovanni</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility</article-title>
<source/>Neuroscience
          <year>2009</year>
<volume>161</volume>
<issue>1</issue>
<fpage>293</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.03.005</pub-id>
<pub-id pub-id-type="pmid">19285115</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The extreme male brain theory of autism</article-title>
<source/>Trends Cogn Sci
          <year>2002</year>
<volume>6</volume>
<issue>6</issue>
<fpage>248</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/S1364-6613(02)01904-6</pub-id>
<pub-id pub-id-type="pmid">12039606</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Frith</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Does the autistic child have a “theory of mind”?</article-title>
<source/>Cognition
          <year>1985</year>
<volume>21</volume>
<issue>1</issue>
<fpage>37</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/0010-0277(85)90022-8</pub-id>
<pub-id pub-id-type="pmid">2934210</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauman</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Iosif</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e278</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.47</pub-id>
<pub-id pub-id-type="pmid">23838889</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becker</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Autism, asthma, inflammation, and the hygiene hypothesis</article-title>
<source/>Med Hypotheses
          <year>2007</year>
<volume>69</volume>
<issue>4</issue>
<fpage>731</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2007.02.019</pub-id>
<pub-id pub-id-type="pmid">17412520</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beart</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>O’Shea</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement</article-title>
<source/>Br J Pharmacol
          <year>2007</year>
<volume>150</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjp.0706949</pub-id>
<pub-id pub-id-type="pmid">17088867</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernardi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anagnostou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kolevzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Hollander</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism</article-title>
<source/>Brain Res
          <year>2011</year>
<volume>1380</volume>
<fpage>198</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.12.057</pub-id>
<pub-id pub-id-type="pmid">21185269</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Krakowiak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Duncanson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Boyce</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism-specific maternal autoantibodies recognize critical proteins in developing brain</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e277</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.50</pub-id>
<pub-id pub-id-type="pmid">23838888</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Krakowiak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism: maternally derived antibodies specific for fetal brain proteins</article-title>
<source/>Neurotoxicology
          <year>2008</year>
<volume>29</volume>
<issue>2</issue>
<fpage>226</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">18078998</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brimberg</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sadiq</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gregersen</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>11</issue>
<fpage>1171</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.101</pub-id>
<pub-id pub-id-type="pmid">23958959</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buehler</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder</article-title>
<source/>Med Hypotheses
          <year>2011</year>
<volume>76</volume>
<issue>6</issue>
<fpage>863</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2011.02.038</pub-id>
<pub-id pub-id-type="pmid">21421290</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camacho</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ariza</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Noctor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Embryonic intraventricular exposure to autism-specific maternal autoantibodies produces alterations in autistic-like stereotypical behaviors in offspring mice</article-title>
<source/>Behav Brain Res
          <year>2014</year>
<volume>266</volume>
<fpage>46</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2014.02.045</pub-id>
<pub-id pub-id-type="pmid">24613242</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castedo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perfettini</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Roumier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe</article-title>
<source/>Cell Death Differ
          <year>2002</year>
<volume>9</volume>
<issue>12</issue>
<fpage>1287</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1038/sj.cdd.4401130</pub-id>
<pub-id pub-id-type="pmid">12478465</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chawarska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shic</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Macari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Brian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Landa</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>18-month predictors of later outcomes in younger siblings of children with autism spectrum disorder: a baby siblings research consortium study</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>2014</year>
<volume>53</volume>
<issue>12</issue>
<fpage>1317</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaac.2014.09.015</pub-id>
<pub-id pub-id-type="pmid">25457930</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Peñagarikano</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Belgard</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Swarup</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>The emerging picture of autism spectrum disorder: genetics and pathology</article-title>
<source/>Annu Rev Pathol
          <year>2015</year>
<volume>10</volume>
<fpage>111</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-pathol-012414-040405</pub-id>
<pub-id pub-id-type="pmid">25621659</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chien</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Gau</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>WH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of HLA-DRB1 alleles and neuropsychological function in autism</article-title>
<source/>Psychiatr Genet
          <year>2012</year>
<volume>22</volume>
<issue>1</issue>
<fpage>46</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1097/YPG.0b013e32834915ae</pub-id>
<pub-id pub-id-type="pmid">21716163</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clifford</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dissanayake</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bui</surname>
<given-names>QM</given-names>
</name>
<name>
<surname>Huggins</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Loesch</surname>
<given-names>DZ</given-names>
</name>
</person-group>
<article-title>Autism spectrum phenotype in males and females with fragile X full mutation and premutation</article-title>
<source/>J Autism Dev Disord
          <year>2007</year>
<volume>37</volume>
<issue>4</issue>
<fpage>738</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-006-0205-z</pub-id>
<pub-id pub-id-type="pmid">17031449</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Solso</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Brain growth across the life span in autism: age-specific changes in anatomical pathology</article-title>
<source/>Brain Res
          <year>2011</year>
<volume>1380</volume>
<fpage>138</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.101</pub-id>
<pub-id pub-id-type="pmid">20920490</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mouton</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Semendeferi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ahrens-Barbeau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hallet</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuron number and size in prefrontal cortex of children with autism</article-title>
<source/>JAMA
          <year>2011</year>
<volume>306</volume>
<issue>18</issue>
<fpage>2001</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2011.1638</pub-id>
<pub-id pub-id-type="pmid">22068992</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Goines</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>JK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study</article-title>
<source/>Autism Res
          <year>2008</year>
<volume>1</volume>
<issue>2</issue>
<fpage>130</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1002/aur.14</pub-id>
<pub-id pub-id-type="pmid">19119429</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Haapanen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Fireman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>JK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study</article-title>
<source/>Biol Psychiatry
          <year>2008</year>
<volume>64</volume>
<issue>7</issue>
<fpage>583</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2008.05.006</pub-id>
<pub-id pub-id-type="pmid">18571628</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cusco</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Medrano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gener</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Vilardell</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gallastegui</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder</article-title>
<source/>Hum Mol Genet
          <year>2009</year>
<volume>18</volume>
<issue>10</issue>
<fpage>1795</fpage>
<lpage>804</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp092</pub-id>
<pub-id pub-id-type="pmid">19246517</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deitmer</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Broer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Broer</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Glutamine efflux from astrocytes is mediated by multiple pathways</article-title>
<source/>J Neurochem
          <year>2003</year>
<volume>87</volume>
<issue>1</issue>
<fpage>127</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01981.x</pub-id>
<pub-id pub-id-type="pmid">12969260</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deverman</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Cytokines and CNS development</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<issue>1</issue>
<fpage>61</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.002</pub-id>
<pub-id pub-id-type="pmid">19840550</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeVito</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Drost</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Neufeld</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Rajakumar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pavlosky</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study</article-title>
<source/>Biol Psychiatry
          <year>2007</year>
<volume>61</volume>
<issue>4</issue>
<fpage>465</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.07.022</pub-id>
<pub-id pub-id-type="pmid">17276747</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<mixed-citation publication-type="other">DSM-IV® Sourcebook (1994) American Psychiatric Association. ISBN 978-0-89042-025-6.</mixed-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<mixed-citation publication-type="other">DSM-V® Sourcebook (2013) American Psychiatric Association. ISBN 978-0-89042-065-2</mixed-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doshi-Velez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kohane</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis</article-title>
<source/>Pediatrics
          <year>2014</year>
<volume>133</volume>
<issue>1</issue>
<fpage>e54</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2013-0819</pub-id>
<pub-id pub-id-type="pmid">24323995</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engstrom</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karlsson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand</article-title>
<source/>Exp Hematol
          <year>2003</year>
<volume>31</volume>
<issue>4</issue>
<fpage>316</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/S0301-472X(03)00002-X</pub-id>
<pub-id pub-id-type="pmid">12691919</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enstrom</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Onore</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Differential monocyte responses to TLR ligands in children with autism spectrum disorders</article-title>
<source/>Brain Behav Immun
          <year>2010</year>
<volume>24</volume>
<issue>1</issue>
<fpage>64</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2009.08.001</pub-id>
<pub-id pub-id-type="pmid">19666104</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Stary</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Halt</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Realmuto</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum</article-title>
<source/>J Autism Dev Disord
          <year>2001</year>
<volume>31</volume>
<issue>6</issue>
<fpage>529</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1023/A:1013234708757</pub-id>
<pub-id pub-id-type="pmid">11814262</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frith</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>A new look at language and communication in autism</article-title>
<source/>Br J Disord Commun
          <year>1989</year>
<volume>24</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.3109/13682828909011952</pub-id>
<pub-id pub-id-type="pmid">2690916</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujii</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kagami</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Function of the frontal lobe in autistic individuals: a proton magnetic resonance spectroscopic study</article-title>
<source/>J Med Invest
          <year>2010</year>
<volume>57</volume>
<issue>1-2</issue>
<fpage>35</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.2152/jmi.57.35</pub-id>
<pub-id pub-id-type="pmid">20299741</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Azizian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>DeVincent</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tudorica</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kesner-Baruch</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders</article-title>
<source/>J Child Neurol
          <year>2008</year>
<volume>23</volume>
<issue>7</issue>
<fpage>766</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1177/0883073808315423</pub-id>
<pub-id pub-id-type="pmid">18487520</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>YX</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>FC</given-names>
</name>
</person-group>
<article-title>Experimental study on the therapeutic mechanism of high dose intravenous immunoglobulin in treatment of immune-mediated peripheral neuropathy</article-title>
<source/>Zhonghua Er Ke Za Zhi
          <year>2003</year>
<volume>41</volume>
<issue>9</issue>
<fpage>684</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">14733812</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garty</surname>
<given-names>BZ</given-names>
</name>
<name>
<surname>Ludomirsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Danon</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Placental transfer of immunoglobulin G subclasses</article-title>
<source/>Clin Diagn Lab Immunol
          <year>1994</year>
<volume>1</volume>
<issue>6</issue>
<fpage>667</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">8556518</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaugler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Bodea</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Most genetic risk for autism resides with common variation</article-title>
<source/>Nat Genet
          <year>2014</year>
<volume>46</volume>
<issue>8</issue>
<fpage>881</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3039</pub-id>
<pub-id pub-id-type="pmid">25038753</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Levitt</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorders: developmental disconnection syndromes</article-title>
<source/>Curr Opin Neurobiol
          <year>2007</year>
<volume>17</volume>
<issue>1</issue>
<fpage>103</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2007.01.009</pub-id>
<pub-id pub-id-type="pmid">17275283</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<mixed-citation publication-type="other">Geschwind DH, State MW. Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 2015;16.</mixed-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Missing pieces in the NF-kappaB puzzle</article-title>
<source/>Cell
          <year>2002</year>
<volume>109</volume>
<issue>Suppl</issue>
<fpage>S81</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00703-1</pub-id>
<pub-id pub-id-type="pmid">11983155</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>May</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses</article-title>
<source/>Annu Rev Immunol
          <year>1998</year>
<volume>16</volume>
<fpage>225</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.immunol.16.1.225</pub-id>
<pub-id pub-id-type="pmid">9597130</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goines</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study</article-title>
<source/>Mol Autism
          <year>2011</year>
<volume>2</volume>
<fpage>13-2392-2-13</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-2-13</pub-id>
<pub-id pub-id-type="pmid">21810230</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Happé</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Frith</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>The weak coherence account: detail-focused cognitive style in autism spectrum disorders</article-title>
<source/>J Autism Dev Disord
          <year>2006</year>
<volume>36</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-005-0039-0</pub-id>
<pub-id pub-id-type="pmid">16450045</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hay</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Upstream and downstream of mTOR</article-title>
<source/>Genes Dev
          <year>2004</year>
<volume>18</volume>
<issue>16</issue>
<fpage>1926</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1212704</pub-id>
<pub-id pub-id-type="pmid">15314020</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herman</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Butter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Enrile</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prior</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly</article-title>
<source/>Am J Med Genet A
          <year>2007</year>
<volume>143</volume>
<issue>6</issue>
<fpage>589</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.31619</pub-id>
<pub-id pub-id-type="pmid">17286265</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herman</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Henninger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ratliff-Schaub</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>Genetic testing in autism: how much is enough?</article-title>
<source/>Genet Med
          <year>2007</year>
<volume>9</volume>
<issue>5</issue>
<fpage>268</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e31804d683b</pub-id>
<pub-id pub-id-type="pmid">17505203</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertz</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>The astrocyte-neuron lactate shuttle: a challenge of a challenge</article-title>
<source/>J Cereb Blood Flow Metab
          <year>2004</year>
<volume>24</volume>
<issue>11</issue>
<fpage>1241</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1097/00004647-200411000-00008</pub-id>
<pub-id pub-id-type="pmid">15545919</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horder</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lavender</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mendez</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>O’Gorman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [<sup>1</sup>H]MRS study</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e279</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.53</pub-id>
<pub-id pub-id-type="pmid">23838890</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Hsien</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>McCue</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<issue>7</issue>
<fpage>1451</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id>
<pub-id pub-id-type="pmid">24315484</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Cytokine effects on glutamate uptake by human astrocytes</article-title>
<source/>Neuroimmunomodulation
          <year>2000</year>
<volume>7</volume>
<issue>3</issue>
<fpage>153</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1159/000026433</pub-id>
<pub-id pub-id-type="pmid">10754403</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<issue>16</issue>
<fpage>7455</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1001006107</pub-id>
<pub-id pub-id-type="pmid">20378837</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Buyske</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mars</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Sreenath</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stenroos</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>TA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy</article-title>
<source/>Arch Pediatr Adolesc Med
          <year>2009</year>
<volume>163</volume>
<issue>6</issue>
<fpage>542</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1001/archpediatrics.2009.74</pub-id>
<pub-id pub-id-type="pmid">19487610</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jyonouchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Itokazu</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder</article-title>
<source/>Neuropsychobiology
          <year>2002</year>
<volume>46</volume>
<issue>2</issue>
<fpage>76</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1159/000065416</pub-id>
<pub-id pub-id-type="pmid">12378124</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kern</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>The possible role of the cerebellum in autism/PDD: disruption of a multisensory feedback loop</article-title>
<source/>Med Hypotheses
          <year>2002</year>
<volume>59</volume>
<issue>3</issue>
<fpage>255</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-9877(02)00212-8</pub-id>
<pub-id pub-id-type="pmid">12208149</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klauck</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Genetics of autism spectrum disorder</article-title>
<source/>Eur J Hum Genet
          <year>2006</year>
<volume>14</volume>
<issue>6</issue>
<fpage>714</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5201610</pub-id>
<pub-id pub-id-type="pmid">16721407</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knuesel</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chicha</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Britschgi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schobel</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Bodmer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hellings</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal immune activation and abnormal brain development across CNS disorders</article-title>
<source/>Nat Rev Neurol
          <year>2014</year>
<volume>10</volume>
<issue>11</issue>
<fpage>643</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2014.187</pub-id>
<pub-id pub-id-type="pmid">25311587</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Subgrouping the autism “spectrum”: reflections on DSM-5</article-title>
<source/>PLoS Biol
          <year>2013</year>
<volume>11</volume>
<issue>4</issue>
<fpage>e1001544</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1001544</pub-id>
<pub-id pub-id-type="pmid">23630456</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
</person-group>
<article-title>Astrocytes: glutamate transport and alternate splicing of transporters</article-title>
<source/>Int J Biochem Cell Biol
          <year>2010</year>
<volume>42</volume>
<issue>12</issue>
<fpage>1901</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocel.2010.09.016</pub-id>
<pub-id pub-id-type="pmid">20883814</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brott</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Kirkby</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Adelson</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Feller</surname>
<given-names>MB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synapse elimination and learning rules co-regulated by MHC class I H2-Db</article-title>
<source/>Nature
          <year>2014</year>
<volume>509</volume>
<issue>7499</issue>
<fpage>195</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1038/nature13154</pub-id>
<pub-id pub-id-type="pmid">24695230</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Champagne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Elter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Offenbacher</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice</article-title>
<source/>Infect Immun
          <year>2003</year>
<volume>71</volume>
<issue>9</issue>
<fpage>5156</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.71.9.5156-5162.2003</pub-id>
<pub-id pub-id-type="pmid">12933859</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tauqeer</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sheikh</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nagori</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NF-κB signaling in the brain of autistic subjects</article-title>
<source/>Mediators Inflamm
          <year>2011</year>
<volume>2011</volume>
<fpage>785265</fpage>
<pub-id pub-id-type="doi">10.1155/2011/785265</pub-id>
<pub-id pub-id-type="pmid">22046080</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Braunschweig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cabanlit</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>DG</given-names>
</name>
</person-group>
<article-title>Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism</article-title>
<source/>Brain Behav Immun
          <year>2008</year>
<volume>22</volume>
<issue>6</issue>
<fpage>806</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2007.12.007</pub-id>
<pub-id pub-id-type="pmid">18262386</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Quintana</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Glozier</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Hickie</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Guastella</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<issue>4</issue>
<fpage>440</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.59</pub-id>
<pub-id pub-id-type="pmid">24934179</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McAllister</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Major histocompatibility complex I in brain development and schizophrenia</article-title>
<source/>Biol Psychiatry
          <year>2014</year>
<volume>75</volume>
<issue>4</issue>
<fpage>262</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.10.003</pub-id>
<pub-id pub-id-type="pmid">24199663</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mondino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>mTOR at the crossroads of T cell proliferation and tolerance</article-title>
<source/>Semin Immunol
          <year>2007</year>
<volume>19</volume>
<issue>3</issue>
<fpage>162</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/j.smim.2007.02.008</pub-id>
<pub-id pub-id-type="pmid">17383196</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Chana</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Achim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Semendeferi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Buckwalter</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism</article-title>
<source/>Biol Psychiatry
          <year>2010</year>
<volume>68</volume>
<issue>4</issue>
<fpage>368</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.05.024</pub-id>
<pub-id pub-id-type="pmid">20674603</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murdoch</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Recent developments in the genetics of autism spectrum disorders</article-title>
<source/>Curr Opin Genet Dev
          <year>2013</year>
<volume>23</volume>
<issue>3</issue>
<fpage>310</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.gde.2013.02.003</pub-id>
<pub-id pub-id-type="pmid">23537858</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naik</surname>
<given-names>US</given-names>
</name>
<name>
<surname>Gangadharan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abbagani</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nagalla</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dasari</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Manna</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>A study of nuclear transcription factor-kappa B in childhood autism</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<issue>5</issue>
<fpage>e19488</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0019488</pub-id>
<pub-id pub-id-type="pmid">21573053</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuhaus</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Beauchaine</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Neurobiological correlates of social functioning in autism</article-title>
<source/>Clin Psychol Rev
          <year>2010</year>
<volume>30</volume>
<issue>6</issue>
<fpage>733</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.cpr.2010.05.007</pub-id>
<pub-id pub-id-type="pmid">20570622</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordahl</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Barnett</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buonocore</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain enlargement is associated with regression in preschool-age boys with autism spectrum disorders</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>108</volume>
<issue>50</issue>
<fpage>20195</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1107560108</pub-id>
<pub-id pub-id-type="pmid">22123952</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordahl</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Buonocore</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: a longitudinal study</article-title>
<source/>Arch Gen Psychiatry
          <year>2012</year>
<volume>69</volume>
<issue>1</issue>
<fpage>53</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.145</pub-id>
<pub-id pub-id-type="pmid">22213789</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>O’Dushlaine &amp; The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium</collab>
</person-group>
<article-title>Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</article-title>
<source/>Nat Neurosci
          <year>2015</year>
<volume>18</volume>
<fpage>199</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3922</pub-id>
<pub-id pub-id-type="pmid">25599223</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozonoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Farnham</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Pennington</surname>
<given-names>BF</given-names>
</name>
</person-group>
<article-title>Can standard measures identify subclinical markers of autism?</article-title>
<source/>J Autism Dev Disord
          <year>1993</year>
<volume>23</volume>
<issue>3</issue>
<fpage>429</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1007/BF01046049</pub-id>
<pub-id pub-id-type="pmid">8226580</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pahl</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Activators and target genes of Rel/NF-kappaB transcription factors</article-title>
<source/>Oncogene
          <year>1999</year>
<volume>18</volume>
<issue>49</issue>
<fpage>6853</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1203239</pub-id>
<pub-id pub-id-type="pmid">10602461</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paolicelli</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>CT</given-names>
</name>
</person-group>
<article-title>Microglia in development: linking brain wiring to brain environment</article-title>
<source/>Neuron Glia Biol
          <year>2011</year>
<volume>7</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1017/S1740925X12000105</pub-id>
<pub-id pub-id-type="pmid">22857738</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pardo</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Immunity, neuroglia and neuroinflammation in autism</article-title>
<source/>Int Rev Psychiatry
          <year>2005</year>
<volume>17</volume>
<issue>6</issue>
<fpage>485</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1080/02646830500381930</pub-id>
<pub-id pub-id-type="pmid">16401547</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Immune involvement in schizophrenia and autism: etiology, pathology, and animal models</article-title>
<source/>Behav Brain Res
          <year>2008</year>
<volume>12</volume>
<fpage>121</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>ND</given-names>
</name>
</person-group>
<article-title>NF-kappaB: tumor promoter or suppressor?</article-title>
<source/>Trends Cell Biol
          <year>2004</year>
<volume>14</volume>
<issue>2</issue>
<fpage>64</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2003.12.004</pub-id>
<pub-id pub-id-type="pmid">15102437</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaisted</surname>
<given-names>K</given-names>
</name>
<name>
<surname>O’Riordan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Enhanced visual search for a conjunctive target in autism: a research note</article-title>
<source/>J Child Psychol Psychiatry
          <year>1998</year>
<volume>39</volume>
<fpage>777</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1017/S0021963098002613</pub-id>
<pub-id pub-id-type="pmid">9690940</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaisted</surname>
<given-names>K</given-names>
</name>
<name>
<surname>O’Riordan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Enhanced discrimination of novel, highly similar stimuli by adults with autism during a perceptual learning task</article-title>
<source/>J Child Psychol Psychiatry
          <year>1998</year>
<volume>39</volume>
<fpage>765</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1017/S0021963098002601</pub-id>
<pub-id pub-id-type="pmid">9690939</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabowo</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Anink</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Spliet</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Rijen</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Aronica</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions</article-title>
<source/>J Neuroinflammation
          <year>2013</year>
<volume>10</volume>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-10-12</pub-id>
<pub-id pub-id-type="pmid">23347564</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pramparo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Carter Barnes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marinero</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ahrens-Barbeau</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prediction of autism by translation and immune/inflammation coexpressed genes in toddlers from pediatric community practices</article-title>
<source/>JAMA Psychiatry
          <year>2015</year>
<volume>72</volume>
<issue>4</issue>
<fpage>386</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.3008</pub-id>
<pub-id pub-id-type="pmid">25739104</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sacco</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Militerni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Frolli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bravaccio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gritti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elia</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical, morphological, and biochemical correlates of head circumference in autism</article-title>
<source/>Biol Psychiatry
          <year>2007</year>
<volume>62</volume>
<issue>9</issue>
<fpage>1038</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.04.039</pub-id>
<pub-id pub-id-type="pmid">17644070</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadiq</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Slator</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Skuse</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Minnis</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Social use of language in children with reactive attachment disorder and autism spectrum disorders</article-title>
<source/>Eur Child Adolesc Psychiatry
          <year>2012</year>
<volume>21</volume>
<issue>5</issue>
<fpage>267</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1007/s00787-012-0259-8</pub-id>
<pub-id pub-id-type="pmid">22392258</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hertweck</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Leleu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Spivakov</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2008</year>
<volume>105</volume>
<issue>22</issue>
<fpage>7797</fpage>
<lpage>802</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0800928105</pub-id>
<pub-id pub-id-type="pmid">18509048</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schumann</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Nordahl</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>Bridging the gap between MRI and postmortem research in autism</article-title>
<source/>Brain Res.
          <year>2011</year>
<volume>1380</volume>
<fpage>175</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.061</pub-id>
<pub-id pub-id-type="pmid">20869352</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guest</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Rahmoune</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ingudomnukul</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex-specific serum biomarker patterns in adults with Asperger’s syndrome</article-title>
<source/>Mol Psychiatry
          <year>2011</year>
<volume>16</volume>
<issue>12</issue>
<fpage>1213</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2010.102</pub-id>
<pub-id pub-id-type="pmid">20877284</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Pow</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Buljan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distribution of glutamate transporter GLAST in membranes of cultured astrocytes in the presence of glutamate transport substrates and ATP</article-title>
<source/>Neurochem Res
          <year>2009</year>
<volume>34</volume>
<issue>10</issue>
<fpage>1758</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-009-9982-z</pub-id>
<pub-id pub-id-type="pmid">19440835</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shatz</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>MHC class I: an unexpected role in neuronal plasticity</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<issue>1</issue>
<fpage>40</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.09.044</pub-id>
<pub-id pub-id-type="pmid">19840547</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gause</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Pletnikov</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model</article-title>
<source/>J Neuroimmunol
          <year>2009</year>
<volume>211</volume>
<issue>1-2</issue>
<fpage>39</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2009.03.011</pub-id>
<pub-id pub-id-type="pmid">19362378</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bera</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>De</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chaudhuri</surname>
<given-names>TK</given-names>
</name>
</person-group>
<article-title>Study of HLA class I gene in Indian schizophrenic patients of Siliguri, West Bengal</article-title>
<source/>Psychiatry Res
          <year>2011</year>
<volume>189</volume>
<issue>2</issue>
<fpage>215</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2011.03.010</pub-id>
<pub-id pub-id-type="pmid">21459456</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steeb</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ramsey</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Guest</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Stocki</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Rahmoune</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome</article-title>
<source/>Mol Autism
          <year>2014</year>
<volume>5</volume>
<issue>1</issue>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-4</pub-id>
<pub-id pub-id-type="pmid">24467795</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stubbs</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Budden</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Terdal</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Ritvo</surname>
<given-names>ER</given-names>
</name>
</person-group>
<article-title>Effects of fenfluramine on eight outpatients with the syndrome of autism</article-title>
<source/>Dev Med Child Neurol
          <year>1986</year>
<volume>28</volume>
<issue>2</issue>
<fpage>229</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.1986.tb03859.x</pub-id>
<pub-id pub-id-type="pmid">3709993</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stubbs</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Ritvo</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Mason-Brothers</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Autism and shared parental HLA antigens</article-title>
<source/>J Am Acad Child Psychiatry
          <year>1985</year>
<volume>24</volume>
<issue>2</issue>
<fpage>182</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/S0002-7138(09)60445-3</pub-id>
<pub-id pub-id-type="pmid">3989160</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsuzaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kameno</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimmura</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<issue>5</issue>
<fpage>e20470</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0020470</pub-id>
<pub-id pub-id-type="pmid">21647375</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Etherton</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Hammer</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice</article-title>
<source/>Science
          <year>2007</year>
<volume>318</volume>
<fpage>71</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1126/science.1146221</pub-id>
<pub-id pub-id-type="pmid">17823315</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tincani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rebaioli</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Frassi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taglietti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gorla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cavazzana</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome</article-title>
<source/>Autoimmun Rev
          <year>2005</year>
<volume>4</volume>
<issue>7</issue>
<fpage>423</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2005.03.001</pub-id>
<pub-id pub-id-type="pmid">16137607</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vargas</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Nascimbene</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Pardo</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Neuroglial activation and neuroinflammation in the brain of patients with autism</article-title>
<source/>Ann Neurol
          <year>2005</year>
<volume>57</volume>
<issue>1</issue>
<fpage>67</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1002/ana.20315</pub-id>
<pub-id pub-id-type="pmid">15546155</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<issue>7351</issue>
<fpage>380</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<pub-id pub-id-type="pmid">21614001</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Eapen</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Converging pathways in autism spectrum disorders: interplay between synaptic dysfunction and immune responses</article-title>
<source/>Front Hum Neurosci
          <year>2013</year>
<volume>7</volume>
<fpage>738</fpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2013.00738</pub-id>
<pub-id pub-id-type="pmid">24223544</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Odell</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Pingree</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>White</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detection of maternal antibodies in infantile autism</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>1990</year>
<volume>29</volume>
<issue>6</issue>
<fpage>873</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199011000-00005</pub-id>
<pub-id pub-id-type="pmid">2273013</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Hersh</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Brief report: the association of neurofibromatosis type 1 and autism</article-title>
<source/>J Autism Dev Disord
          <year>1998</year>
<volume>28</volume>
<issue>6</issue>
<fpage>567</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1023/A:1026012414193</pub-id>
<pub-id pub-id-type="pmid">9932243</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiznitzer</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Autism and tuberous sclerosis</article-title>
<source/>J Child Neurol
          <year>2004</year>
<volume>19</volume>
<issue>9</issue>
<fpage>675</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">15563013</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suckling</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Powis</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation</article-title>
<source/>Front Psychiatry
          <year>2011</year>
<volume>2</volume>
<fpage>27</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2011.00027</pub-id>
<pub-id pub-id-type="pmid">21629840</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Powis</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>TNF-α induction of murine brain inflammation via IKK/NF kappa B signalling: a potential model for autism</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<issue>6</issue>
<fpage>e39049</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0039049</pub-id>
<pub-id pub-id-type="pmid">22701747</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Connors</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Matteson</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Castaneda</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Maternal antibrain antibodies in autism</article-title>
<source/>Brain Behav Immun
          <year>2007</year>
<volume>21</volume>
<issue>3</issue>
<fpage>351</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2006.08.005</pub-id>
<pub-id pub-id-type="pmid">17029701</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmerman</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Jyonouchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Comi</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Connors</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Milstien</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Varsou</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebrospinal fluid and serum markers of inflammation in autism</article-title>
<source/>Pediatr Neurol
          <year>2005</year>
<volume>33</volume>
<issue>3</issue>
<fpage>195</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2005.03.014</pub-id>
<pub-id pub-id-type="pmid">16139734</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>